Although few studies are correlating the action of either G9a/GLP or GLP blocking separately with ALL, the data we have so far indicates that control of the G9a/GLP pathway represents a potential treatment for ALL [103]. The gene discussed is EHMT1; the disease is acute lymphoblastic leukemia.